Back to search
FDAFDA · Food and drugs·Recall number D-1269-2020

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Published May 20, 2020 · Recall initiated: April 14, 2020

Summary

FDA records drug Class I recall D-1269-2020, published May 20, 2020 and initiated April 14, 2020. Recalling firm: MasterPharm LLC; Status: Terminated; Reported quantity: 7260 capsules; Lot: Lot #02-27-2020:04@11, Exp. August 25, 2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MasterPharm LLC
Distributor
Nationwide in the U.S.
Lot
Lot #02-27-2020:04@11, Exp. August 25, 2020.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419. recalled?

Yes. FDA published recall D-1269-2020 on May 20, 2020. Reported hazard: Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone